IL92238A0 - - Google Patents

Info

Publication number
IL92238A0
IL92238A0 IL92238A IL9223889A IL92238A0 IL 92238 A0 IL92238 A0 IL 92238A0 IL 92238 A IL92238 A IL 92238A IL 9223889 A IL9223889 A IL 9223889A IL 92238 A0 IL92238 A0 IL 92238A0
Authority
IL
Israel
Prior art keywords
designates
chained
straight
branched
radical
Prior art date
Application number
IL92238A
Other languages
English (en)
Other versions
IL92238A (en
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to IL9223889A priority Critical patent/IL92238A/en
Application filed filed Critical
Publication of IL92238A0 publication Critical patent/IL92238A0/xx
Priority to ES90312147T priority patent/ES2071786T3/es
Priority to DK90312147.3T priority patent/DK0427518T3/da
Priority to AU65834/90A priority patent/AU631262B2/en
Priority to AT90312147T priority patent/ATE119898T1/de
Priority to DE69017839T priority patent/DE69017839T2/de
Priority to EP90312147A priority patent/EP0427518B1/en
Priority to ZA908914A priority patent/ZA908914B/xx
Priority to JP2302296A priority patent/JPH0768235B2/ja
Priority to KR1019900018114A priority patent/KR950005914B1/ko
Priority to CA002029419A priority patent/CA2029419C/en
Priority to US07/865,088 priority patent/US5284867A/en
Priority to US08/192,886 priority patent/US5521215A/en
Publication of IL92238A publication Critical patent/IL92238A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/78—Ring systems having three or more relevant rings
    • C07D311/80—Dibenzopyrans; Hydrogenated dibenzopyrans

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Toxicology (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyrane Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
IL9223889A 1989-11-07 1989-11-07 ADMN blocking product containing tetrahydrocannabinol history, several new tetrahydrocannabinol histories and process for their preparation IL92238A (en)

Priority Applications (13)

Application Number Priority Date Filing Date Title
IL9223889A IL92238A (en) 1989-11-07 1989-11-07 ADMN blocking product containing tetrahydrocannabinol history, several new tetrahydrocannabinol histories and process for their preparation
ES90312147T ES2071786T3 (es) 1989-11-07 1990-11-06 Compuestos bloqueadores de nmda, composiciones farmaceuticas, su preparacion y su uso.
DK90312147.3T DK0427518T3 (da) 1989-11-07 1990-11-06 NMDA-blokerende forbindelser, farmaceutiske præparater, deres fremstilling og anvendelse
AU65834/90A AU631262B2 (en) 1989-11-07 1990-11-06 Nmda-blocking pharmaceutical compositions
AT90312147T ATE119898T1 (de) 1989-11-07 1990-11-06 Nmda-blockierende verbindungen, pharmazeutische präparate, deren herstellung und verwendung.
DE69017839T DE69017839T2 (de) 1989-11-07 1990-11-06 NMDA-blockierende Verbindungen, pharmazeutische Präparate, deren Herstellung und Verwendung.
EP90312147A EP0427518B1 (en) 1989-11-07 1990-11-06 NMDA-Blocking compounds, pharmaceutical compositions, their preparation and use
ZA908914A ZA908914B (en) 1989-11-07 1990-11-07 Nmda-blocking pharmaceutical composition
CA002029419A CA2029419C (en) 1989-11-07 1990-11-07 Nmda-blocking pharmaceutical compositions
JP2302296A JPH0768235B2 (ja) 1989-11-07 1990-11-07 Ｎｍｄａ遮断薬剤組成物
KR1019900018114A KR950005914B1 (ko) 1989-11-07 1990-11-07 Nmda-차단 제약조성물
US07/865,088 US5284867A (en) 1989-11-07 1992-04-08 NMDA-blocking pharmaceutical compositions
US08/192,886 US5521215A (en) 1989-11-07 1994-02-07 NMDA-blocking pharmaceuticals

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IL9223889A IL92238A (en) 1989-11-07 1989-11-07 ADMN blocking product containing tetrahydrocannabinol history, several new tetrahydrocannabinol histories and process for their preparation

Publications (2)

Publication Number Publication Date
IL92238A0 true IL92238A0 (zh) 1990-07-26
IL92238A IL92238A (en) 1995-07-31

Family

ID=11060554

Family Applications (1)

Application Number Title Priority Date Filing Date
IL9223889A IL92238A (en) 1989-11-07 1989-11-07 ADMN blocking product containing tetrahydrocannabinol history, several new tetrahydrocannabinol histories and process for their preparation

Country Status (11)

Country Link
EP (1) EP0427518B1 (zh)
JP (1) JPH0768235B2 (zh)
KR (1) KR950005914B1 (zh)
AT (1) ATE119898T1 (zh)
AU (1) AU631262B2 (zh)
CA (1) CA2029419C (zh)
DE (1) DE69017839T2 (zh)
DK (1) DK0427518T3 (zh)
ES (1) ES2071786T3 (zh)
IL (1) IL92238A (zh)
ZA (1) ZA908914B (zh)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6017903A (en) 1996-09-27 2000-01-25 Guilford Pharmaceuticals Inc. Pharmaceutical compositions and methods of treating a glutamate abnormality and effecting a neuronal activity in an animal using NAALADase inhibitors
US5824662A (en) 1996-09-27 1998-10-20 Guilford Pharmaceuticals Inc. Treatment of global and focal ischemia using naaladase inhibitors
WO1998013046A1 (en) 1996-09-27 1998-04-02 Guilford Pharmaceuticals Inc. Naaladase compositions and methods for treating glutamate abnormality and effecting neuronal activity in animals
DE19706903A1 (de) 1997-02-21 1998-08-27 Bayer Ag Verwendung von bekannten Agonisten des zentralen Cannabinoid-Rezeptors CB 1
JP2002501510A (ja) * 1997-05-07 2002-01-15 ユニメッド・ファーマシューティカルズ・インコーポレーテッド ヒトにおける攪乱行動を改善し気分を高揚させる方法
ATE367809T1 (de) * 1998-04-21 2007-08-15 Us Health Cannabinoiden als antioxidantien und neuroschützende mittel
KR20080063800A (ko) 2005-09-29 2008-07-07 에이엠알 테크놀로지, 인크. 델타-9-테트라히드로칸나비놀의 제조 방법
DE102015112092B4 (de) 2015-07-24 2022-03-10 Beko Technologies Gmbh Öl/Wasser-Trennvorrichtung mit Druckluftbeaufschlagung

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL48824A (en) * 1976-01-12 1980-05-30 Yissum Res Dev Co Pharmaceutical compositions containing (3s,js) tetrahydrocanabinol derivatives and some novel compounds of this type
US4133819A (en) * 1977-06-17 1979-01-09 Pfizer Inc. Hexahydro-1-hydroxy-9-hydroxymethyl-3-substituted-6H-dibenzo[b,d]pyrans as analgesic agents
US4209520A (en) * 1977-06-17 1980-06-24 Pfizer Inc. Hexahydro-1-hydroxy-9-hydroxymethyl-3-substituted-6H-dibenzo[b,d]pyrans as analgesic agents
IL80411A (en) * 1986-10-24 1991-08-16 Raphael Mechoulam Preparation of dibenzopyranol derivatives and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
AU631262B2 (en) 1992-11-19
ATE119898T1 (de) 1995-04-15
JPH0768235B2 (ja) 1995-07-26
KR910009687A (ko) 1991-06-28
IL92238A (en) 1995-07-31
ZA908914B (en) 1991-09-25
DE69017839D1 (de) 1995-04-20
JPH03209377A (ja) 1991-09-12
DE69017839T2 (de) 1995-08-31
KR950005914B1 (ko) 1995-06-07
CA2029419A1 (en) 1991-05-08
EP0427518B1 (en) 1995-03-15
AU6583490A (en) 1991-05-30
ES2071786T3 (es) 1995-07-01
DK0427518T3 (da) 1995-07-24
EP0427518A1 (en) 1991-05-15
CA2029419C (en) 2004-05-25

Similar Documents

Publication Publication Date Title
GR3004902T3 (zh)
PH24503A (en) New pharmaceutical compositions having psychotropic activity
EP0378518A3 (en) Adenosine derivatives having pharmaceutical activity as antihypertensives
PT1004578E (pt) Derivados hidroxamida do acido 5-oxo-pirrolidino-2-carboxilico
IL87908A (en) Azaspirane derivatives and immunomodulating pharmaceutical compositions containing same
IL105827A0 (en) Thienobenzodiazepines,their preparation and pharmaceutical compositions containing them
EP0867183A4 (en) ARYLPIPERIDINOL AND ARYLPIPERIDINE DERIVATIVES AND MEDICAMENTS CONTAINING THEM
PH25859A (en) Composition for treatment of ischemic disorder
CA2103590A1 (en) Benzamide derivative
PL309874A1 (en) Novel derivatives of pyrrolocarbasol, method of obtaining them and pharmaceutical composition containing such derivatives
IL92238A0 (zh)
IL75116A (en) Ethyl substituted-beta-carboxylates,process for the preparation thereof and pharmaceutical compositions containing the same
GR3007401T3 (zh)
TW218016B (zh)
GR3017348T3 (en) Novel isoindolinone derivative, preparation thereof, and pharmaceutical compositions containing same.
NZ222045A (en) From diamides up to tetrapeptides for use as anticanvulsants
GR3007219T3 (zh)
GR3000904T3 (en) Amide derivatives
IL95619A0 (en) N-azabicyclo(3.3.0)octane amides of aromatic acids and pharmaceutical compositions containing them
TW275629B (zh)
DE69405999T2 (de) Pharmazeutisch wirksame enantiomere
GR3021200T3 (en) (Cyclohexyl)-alken compounds, process for their preparation and pharmaceutical compositions containing them.

Legal Events

Date Code Title Description
KB Patent renewed
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees